MedTrace Logo

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

NCT00938457 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2016-05-19

Study results available
· View outcomes & findings →

Summary

RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.

PURPOSE: This phase I/II trial is studying the side effects and best dose of stereotactic radiation therapy in treating patients with liver metastases.

Conditions

  • Unspecified Adult Solid Tumor

Interventions

RADIATION

stereotactic radiation therapy

Patients undergo stereotactic body radiation therapy

PROCEDURE

implanted fiducial-based imaging

radiation therapy treatment planning

PROCEDURE

cone-beam computed tomography

radiation therapy treatment planning

Sponsors & Collaborators

Principal Investigators

  • Robert C. Miller, M.D. · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00938457 on ClinicalTrials.gov